PureTech Health PLC Vor Files IPO Registration Statement on Nasdaq
January 18 2021 - 2:00AM
RNS Non-Regulatory
TIDMPRTC
PureTech Health PLC
18 January 2021
18 January 2021
PureTech Health plc
PureTech Founded Entity Vor Files Public Registration Statement
for Proposed Initial Public Offering
PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) announced that its
Founded Entity, Vor Biopharma Inc. ("Vor"), has filed a public
registration statement on Form S-1 with the U.S. Securities and
Exchange Commission (SEC) relating to a proposed initial public
offering of shares of its common stock. The number of shares to be
offered and the price range for the offering have not yet been
determined. The offering is subject to market conditions, and there
can be no assurance as to whether or when the offering may be
completed, or as to the actual size or terms of the offering. Vor
intends to list its common stock under the symbol " VOR " on The
Nasdaq Global Market.
Goldman Sachs & Co. LLC is the lead book runner for the
proposed offering.
A registration statement relating to these securities has been
filed with the SEC but has not yet become effective. These
securities may not be sold, nor may offers to buy be accepted,
prior to the time the registration statement becomes effective. The
offering will be made only by means of a prospectus. When
available, a copy of the preliminary prospectus may be obtained by
visiting the SEC's website at www.sec.gov or by contacting the
offices of Goldman Sachs & Co. LLC, Attention: Prospectus
Department, 200 West Street, New York, NY 10282, by telephone:
1-866-471-2526 or by emailing prospectus-ny@ny.email.gs.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that are or may be
forward-looking statements, including statements that relate to our
product candidates and approach towards addressing major diseases,
future prospects, developments, and strategies. The forward-looking
statements are based on current expectations and are subject to
known and unknown risks and uncertainties that could cause actual
results, performance and achievements to differ materially from
current expectations, including, but not limited to, expectations
regarding Vor's proposed initial public offering and those risks
and uncertainties described in the risk factors included in the
regulatory filings for PureTech Health plc. These forward-looking
statements are based on assumptions regarding the present and
future business strategies of the company and the environment in
which it will operate in the future. Each forward-looking statement
speaks only as at the date of this press release. Except as
required by law and regulatory requirements, neither the company
nor any other party intends to update or revise these
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contact:
Investors
Allison Mead Talbot
+1 617 651 3156
amt@puretechhealth.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAXDLLFFFLFBBF
(END) Dow Jones Newswires
January 18, 2021 02:00 ET (07:00 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024